Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC
Clinical trial NCT05229003 · UNKNOWN
Trial details
- NCT number
- NCT05229003
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-09
- Primary completion
- 2025-05-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.